Psychedelic Drugs Market Overview: 2025-2030
Base Year: 2024
Historical Years: 2020-23
Forecast Years: 2025-30
The Psychedelic Drugs Market size was valued at around USD 1.92 billion in 2024 and is projected to reach USD 3.8 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 12% during the forecast period, i.e., 2025-30. Increasing awareness about mental health and government Initiatives raising the demand for psychedelic drugs. As per the WHO (World Health Organization), the Global Mental Health, and World Federation for Mental Health, have increased their attention towards mental health and its awareness among consumers worldwide. For instance, the National Alliance of Mental Illness NAMI in 2022, revealed that every year, about 21% of adults in the U.S. are affected by some or other mental health issue and less than half of this population seek professional guidance. Many of them are not aware of the various treatment options.
Markntel Advisor’s Psychedelic Drugs Market Insights report provides the current and forecast market analysis, individual leading companies’ market shares, challenges, Psychedelic Drugs Market drivers, barriers, Psychedelic Drugs Market Trends, and Key Players in Psychedelic Drugs Market.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report: https://www.marknteladvisors.com/query/request-sample/psychedelic-drugs-market.html
Psychedelic Drugs Market Dynamics: 2025-2030
Psychedelic Drugs Market Driver:
Growing Prevalence of Mental Illness – The prevalence of mental illness varies by age and sex and has increased more rapidly than other serious illnesses. There has been an increase in instances of mental health conditions, including anxiety, sleep-wake disorder, and depressive disorders. For instance, as per a survey by MedlinePlus, it was found that excessive time spent on social media was associated with anxiety, depression, negative body image, and psychological distress. It is estimated that 72% of Americans use social media which affects their mental health.
Similarly, the National Alliance on Mental Illness in 2023 found that more than USD 43.8 million people are affected by mental health disorders on account of spending more time on social media. For instance, as per the Mental Health Foundation, in 2021, those aged 16 to 29 years were most likely to have some anxiety and depression and they are estimated to be around 28%. From 2022 to 2023, an average of 37.1% of women and 29.9% of men reported high levels of anxiety. Therefore, health disorders such as psychosis, anxiety, panic attacks, and depression require psychedelic drugs for their treatments. Thus, the increase in anxiety and other mental disorders is expected to increase the demand for psychedelic drugs.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/psychedelic-drugs-market.html
Psychedelic Drugs Market (2025-30): Segmentation Outlook
The market report has segmented the market into the following categories:
- By Source
- Synthetic -Market Size & Forecast 2020-2030 USD Million
- Natural- Market Size & Forecast 2020-2030, USD Million
- By Drugs
- Gamma-Hydroxybutyric Acid-Market Size & Forecast 2020-2030, USD Million
- Ketamine-Market Size & Forecast 2020-2030, USD Million
- Psilocybin-Market Size & Forecast 2020-2030, USD Million
- Lysergic Acid Diethylamide (LSD)-Market Size & Forecast 2020-2030, USD Million
- MethylEnedioxyMethamphetamine-Market Size & Forecast 2020-2030, USD Million
- By Application
- Narcolepsy–Market Size & Forecast 2020-2030, USD Million
- Treatment Resistant Depression-Market Size & Forecast 2020-2030, USD Million
- Major Depressive Disorder-Market Size & Forecast 2020-2030, USD Million
- Opiate Addiction-Market Size & Forecast 2020-2030, USD Million
- Post-Traumatic Stress Disorder-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration
- Oral
- Inhalation–Market Size & Forecast 2020-2030, USD Million
- Injectable-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Psychedelic Drugs Market:
- Jazz Pharmaceuticals, Inc. (U.S.)
- Janssen Pharmaceuticals, Inc. (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Compass
- Pfizer Inc.
- Avadel
- AbbVie Inc.
- Celon Pharma
- GH Research
- Entheon Biomedical Corp
- PharmaTher Holdings Ltd.
- Usona Institute
- Cybin Corp.
- F. Hoffmann-La Roche Ltd
- AstraZeneca PLC
- Numinus Wellness Inc.
- Others
Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India